Evidence map›Paper›PMID 42096476›Full record

ArticlePLoS biology2026

The KMT2F histone methyltransferase interacts with the RNA polymerase I machinery to promote ribosomal RNA transcription.

Kaisar Ahmad Lone, Amit Mahendra Karole, Geethanjali Ravindran, Shweta Tyagi

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaisar Ahmad LoneLaboratory of Cell Cycle Regulation, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Uppal, Hyderabad, India.
Amit Mahendra KaroleLaboratory of Cell Cycle Regulation, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Uppal, Hyderabad, India.
Geethanjali RavindranLaboratory of Cell Cycle Regulation, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Uppal, Hyderabad, India.
Shweta TyagiLaboratory of Cell Cycle Regulation, BRIC-Centre for DNA Fingerprinting and Diagnostics (CDFD), Uppal, Hyderabad, India.ORCID https://orcid.org/0000-0002-8349-6843

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trimethylation of histone 3 lysine 4 (H3K4me3) is a mark of active transcription, and its regulatory role in RNA polymerase II-mediated transcription has been well-studied. However, if and how this mark regulates RNA polymerase I (RNA Pol I) is not known. Here, we used customized genome assemblies for rDNA to demonstrate that KMT2A and KMT2F bind to entire rDNA loci. The binding of these enzymes was mirrored by the binding of H3K4me2 and H3K4me3 marks. Using biochemical assays, we demonstrate the interaction of KMT2-specific subunits with RNA Pol I transcriptional machinery. Our findings reveal KMT2F as the primary KMT depositing the H3K4me3 on rDNA. Loss of H3K4me3 adversely affects the epigenetic landscape and leads to repression of the rDNA locus. Mechanistically, using mammalian cells as a model system, we demonstrate that KMT2F promotes the formation of the pre-initiation complex by RNA Pol I. Our findings highlight the thus far undiscovered role of H3K4me3 in the transcriptional initiation of rDNA genes.

Indexed as

DNA-Binding ProteinsHistone-Lysine N-MethyltransferaseRNA Polymerase IRNA, RibosomalTranscription, GeneticAnimalsDNA, RibosomalHistonesHumansMethylationMyeloid-Lymphoid Leukemia ProteinProtein BindingDNA-Binding ProteinsDNA, Ribosomalhistone H3 trimethyl Lys4Histone-Lysine N-MethyltransferaseHistonesKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinRNA Polymerase IRNA, Ribosomal

Identifiers

PMID42096476
PMCPMC13178980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.